kokusaginine

antimalarial alkaloid from Teclea afzelii; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Breast Neoplasms (Breast Cancer) 01/01/2018 - "Taken together, these results support the potential therapeutic value of kokusaginine as an anti-MDR agent in chemotherapy for breast carcinoma." 01/01/2018 - "The inhibitory effect of kokusaginine on the growth of human breast cancer cells and MDR-resistant cells is mediated by the inhibition of tubulin assembly."

1.	Tubulin

1.	Drug Therapy (Chemotherapy)